At a glance
Short presentation:
The MSc program “Biomedical Engineering and Technology” is organized by the Department of Biomedical Engineering of the University of West Attica, Athens, Greece. It appeals to those holding a Bachelor’s (B.Sc.) University degree related to engineering, technology, life, and health sciences or other relevant to biomedical engineering sciences, who wish for a career change in Biomedical Engineering. The program duration is three (3) academic semesters. During the first and second semesters, educational activities involve a/ classical lectures in the auditorium, b/ hands-on laboratories in specialized labs equipped with biomedical instruments, c/ field visits in companies, research facilities, and healthcare sites, d/ special seminars organized with the collaboration of the industry, and the labor market, and e/ personal and group assignments. The third semester involves the elaboration of the Diploma thesis, which comprises a full-scale research project.
Key info:
- MSc Program Title: “Biomedical Engineering and Technology”
- Organizer: Department of Biomedical Engineering, School of Engineering, University of West Attica, Athens, Greece
- Location: Egaleo Park Campus, Egaleo, Athens, Greece
- Duration: 1.5 years (3 academic semesters)
- Study mode: Full-time. Most, but not all, courses are scheduled after 5pm
- ECTS: 90
- Teaching Language: English
- Tuition fees: 2000 €
Teaching staff:
a/ Invited professors from 8 Universities, 7 countries:
- University of West Attica, Greece (host institution)
- National Kapodistrian University of Athens, Greece
- Instituto Politécnico do Porto, Portugal
- Universidad Rey Juan Carlos, Spain
- Georgia Institute of Technology, USA
- University of Plymouth, UK
- Universitatea Politehnica din București, Romania
- Trier University of Applied Sciences, Germany
b/ Invited Researchers from biomedical engineering research facilities
c/ Invited biomedical engineers from the labor market
National and International accreditation:
The MSc program MSc program “Biomedical Engineering and Technology” has been accredited, fully compliance, till 2030 by the Hellenic Authority for Higher Education (HAHE). The accreditation decision may be found here.
The MSc program MSc program “Biomedical Engineering and Technology” has been accredited, without conditions, till 2029 by the Accreditation, Certification and Quality Assurance Institute (ACQUIN). The accreditation certificate may be found here.
– Announcement of the program at the Official Gazette of the Greek Government (ΦΕΚ) – In Greek
– Announcement of the program structure, rules and regulation at the Official Gazette of the Greek Government (ΦΕΚ) – In Greek
– Rules and regulation of the MSc program – In English
University, Department and MSc program video presentation (8-minutes)
(The video information applies to the academic year 2024-2025. Modifications will take effect from the academic year 2025-2026. Please refer to the new call for applications for updated details).
MSc program short video presentation (3-minutes)
(The video information applies to the academic year 2024-2025. Modifications will take effect from the academic year 2025-2026. Please refer to the new call for applications for updated details).
MSc program extended video presentation (9-minutes)
(The video information applies to the academic year 2024-2025. Modifications will take effect from the academic year 2025-2026. Please refer to the new call for applications for updated details).
The science of biomedical engineering
The Biomedical Engineering (BME) sector is among the biggest industrial sectors worldwide, with tens of thousands of manufacturers producing more than 500,000 different types of biomedical products.
In particular, in 2022 the European medical technology industry employs over 730,000 people in 32,000 companies with a dynamic and increasing job outlook (source: Medtech Europe). Similarly in the US, the biomedical engineering sector currently supports about 19,300 jobs, which are expected to increase up to 6% until 2030 (source: United States Bureau of Labor Statistics).
Considering that a/ modern medicine and biology rely (and evolve) on technology, and b/ ageing of population will boost the necessity for technologies able to support the prolongation of life with good quality of living, biomedical engineers are expected to play a crucial role in the forthcoming technological era.
The COVID-19 pandemic has exploded the requirements for biomedical engineers in the labor market, since management of the pandemic profoundly relies on biomedical technologies.
For example:
- treatment of patients with serious complications may require hospitalization at an Intensive Care Unit, which relies on technologies, such as the vital signs monitors, the mechanical ventilators, the gas/oxygen flow installations, the drug delivery automation, the extracorporeal blood purification, etc
- diagnosis of affected patients requires specific diagnostic examinations, which are possible due to technologies, such as the PCR instruments, the Serology/Antibody instruments, the Rapid Testing Devices, the X-ray Computed Tomography, etc.
- monitoring of the virus mutations/variants, such as the Delta and the Omicron variants, requires sequencers and bioanalyzers, optical instruments and microscopy, bioinformatics, etc.
- epidemiology requires sophisticated data analysis algorithms based on artificial intelligence and deep learning
- research requires specialized instruments and methods for the design/discovery of new vaccines, drugs etc.
Biomedical engineers have been supporting and sustaining all of the above technologies during the period of the pandemic.
Career prospects
Biomedical engineers can be employed into many different areas, such as:
- Biomedical Technology Industry (service, application specialist, sales and marketing, field engineer etc)
- Hospitals, clinics, healthcare centers
- Research and academia
- Computing and information technology
- Other engineering related fields
- Business and administration
- Management and finance
- Start-ups
- Teaching
Program's topics
- In vitro and in vivo diagnostic technologies
- Medical Imaging
- Biomedical instrumentation
- Rehabilitation and biomaterials
- Biomedical informatics
- Artificial intelligence
- Deep learning
- Emergency medicine
- Science, technology, ethics
- Marketing, management and sales
- Research methodology
- Labor market – The biomedical engineering profession
Program's curriculum
| 1ST SEMESTER | R: Required E: Elective |
ECTS | |
| BMET.101 | Biomedical Engineering, Research Methodology and Bioethics | R | 4 |
| BMET.102 | Biology-Biotechnology | R | 5 |
| BMET.103 | Biomedical Engineering and Career Opportunities I | R | 4 |
| BMET.104 | Diagnostic Medical Imaging I | R | 5 |
| BMET.105 | Biostatistics | E | 4 |
| BMET.106 | Machine Learning in Medicine and Biology | E | 4 |
| BMET.107 | Biomedical marketing | E | 4 |
| BMET.108 | Biomaterials Science and Engineering | E | 4 |
| BMET.109 | Applied Neuroanatomy and Neurological Disorders | E | 4 |
| 1st semester courses’ contents |
|||
| 2ND SEMESTER |
R: Required E: Elective |
ECTS | |
| BMET.201 | Diagnostic Medical Imaging II | R | 5 |
| BMET.202 | Biomedical Instrumentation | R | 5 |
| BMET.203 | Biomedical Engineering and Career Opportunities II | R | 5 |
| BMET.204 | Emergency medicine | E | 5 |
| BMET.205 | Control systems and human machine interaction in biomedical engineering | E | 5 |
| BMET.206 | Bioinformatics | E | 5 |
| BMET.207 | Medical Signal and Image Processing | E | 5 |
| BMET.208 | Biomechanics | E | 5 |
| BMET.209 | Continuum Mechanics of Biological and Physiological Systems | E | 5 |
| 2nd semester courses’ contents |
|||
| 3RD SEMESTER | R: Required E: Elective |
ECTS | ||
| BMET.301 | Diploma thesis | Website | R | 30 |
| 3rd semester courses’ contents | ||||
For the successful completion of the program a minimum of ninety (90) ECTS is required, with at least 30 ECTS per semester.
For the 1st and 2nd semester, students should successfully complete all Required courses of each semester (Required courses are assigned with 15 ECTS) and select at least three Elective courses (Elective courses are assigned with 5 ECTS each).
For the 3rd semester, students should successfully complete the Diploma thesis (Diploma thesis is assigned with 30 ECTS).
Steering Committee
The MSc Biomedical Engineering and Technology Steering Committee has the following members:
Dimitris Glotsos, Professor, Department of Biomedical Engineering, University of West Attica, Greece (Director)
Panagiotis Liaparinos, Professor, Department of Biomedical Engineering, University of West Attica, Greece (Member)
Spiros Kostopoulos, Professor (elected), Department of Biomedical Engineering, University of West Attica, Greece (Member)
Stratos David, Associate Professor (elected), Department of Biomedical Engineering, University of West Attica, Greece (Member)
Manolis Athanasiadis, Assistant Professor, Department of Biomedical Engineering, University of West Attica, Greece (Member)
Quality Policy Statement
The University of West Attica has developed and establish procedures of quality assurance policy as a part of its Strategic Planning, approved by the 9th meeting of The Quality Assurance Unit (05.05.2020) and the decision of the 4th meeting of the Senate (08.06.2020).
The MSc Biomedical Engineering and Technology follows the Quality Policy Statement of the University of West Attica.
More info on the Quality Policy Statement of the University of West Attica here. The Quality Policy Statemet of the MSc Biomedical Engineering and Technology can be found here.
Advisory board
The MSc Biomedical Engineering and Technology Advisory Board is composed of three distiguished professionals in the field of biomedical engineering:
- Vourdounis Nikolaos, Sr Service Manager EMEA, Abbot.
- Sidiropoulos Konstantinos, Senior Data and Analytis Engineer, AstraZeneca.
- Kantaros Constantinos, Service engineer, ROSA Medical Robotic Systems.